| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gastroenterology Research Unit, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI, USA
Recent studies indicate that cholecystokinin (CCK) and serotonin (5-hydroxytryptamine, 5-HT) act via vagal afferent fibres to mediate gastrointestinal functions. In the present study, we characterized the interaction between CCK and 5-HT in the vagal primary afferent neurones. Single neuronal discharges of vagal primary afferent neurones innervating the duodenum were recorded from rat nodose ganglia. Two groups of nodose ganglia neurones were identified: group A neurones responded to intra-arterial injection of low doses of cholecystokinin octapeptide (CCK-8; 10–60 pmol); group B neurones responded only to high doses of CCK-8 (120–240 pmol), and were also activated by duodenal distention. CCK-JMV-180, which acts as an agonist in high-affinity states and as an antagonist in low-affinity states, dose dependently stimulated group A neurones, but inhibited the effect of the high doses of CCK-8 on group B neurones. Duodenal perfusion of 5-HT evoked dose-dependent increases in nodose neuronal discharges. Some neurones that responded to 5-HT showed no response to either high or low doses of CCK-8. A separate group of nodose neurones that possessed high-affinity CCK type A (CCK-A) receptors also responded to luminal infusion of 5-HT. Further, a subthreshold dose of CCK-8 (i.e. 5 pmol) produced no measurable electrophysiological effects but it augmented the neuronal responses to 5-HT. This potentiation effect of CCK-8 was eliminated by CR 1409. From these results we concluded that the vagal nodose ganglion contains neurones that may possess only high- or low-affinity CCK-A receptors or 5-HT3 receptors. Some neurones that express high-affinity CCK-A receptors also express 5-HT3 receptors. Pre-exposure to luminal 5-HT may augment the subsequent response to a subthreshold dose of CCK.
(Received 17 March 2004;
accepted after revision 30 June 2004;
first published online 2 July 2004)
Corresponding author Y. Li: Division of Gastroenterology, University of Michigan, 6510 Medical Sciences, Research Building I, 1150 West Medical Center Drive, Ann Arbor, MI 48109-0682, USA. Email: yli{at}umich.edu
This article has been cited by other articles:
|
|
 |
|
  D. M. Savastano, M. R. Hayes, and M. Covasa Serotonin-type 3 receptors mediate intestinal lipid-induced satiation and Fos-like immunoreactivity in the dorsal hindbrain Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2007; 292(3): R1063 - R1070. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Hayes, F. M. Chory, C. A. Gallagher, and M. Covasa Serotonin type-3 receptors mediate cholecystokinin-induced satiation through gastric distension Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2006; 291(1): R115 - R123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Sartor, A. Shulkes, and A. J. M. Verberne An enteric signal regulates putative gastrointestinal presympathetic vasomotor neurons in rats Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R625 - R633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Flemstrom and M. Sjoblom Epithelial Cells and Their Neighbors. II. New perspectives on efferent signaling between brain, neuroendocrine cells, and gut epithelial cells Am J Physiol Gastrointest Liver Physiol, September 1, 2005; 289(3): G377 - G380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Savastano, M. Carelle, and M. Covasa Serotonin-type 3 receptors mediate intestinal Polycose- and glucose-induced suppression of intake Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2005; 288(6): R1499 - R1508. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
